DALLAS, April 25, 2018 -- Texas Capital Bancshares, Inc. (NASDAQ:TCBI), the parent company of Texas Capital Bank, and their board of directors declared a cash dividend of $0.40625 per share of the non-cumulative perpetual preferred stock, Series A, which is traded on the NASDAQ under the symbol “TCBIP”. The Series A Preferred Stock dividend is payable on June 15, 2018, to shareholders of record at the close of business on June 1, 2018.
ABOUT TEXAS CAPITAL BANCSHARES, INC.
Texas Capital Bancshares, Inc. (NASDAQ:TCBI), a member of the Russell 2000® Index and the S&P MidCap 400®, is the parent company of Texas Capital Bank, a commercial bank that delivers highly personalized financial services to businesses and entrepreneurs. Headquartered in Dallas, the bank has full-service locations in Austin, Dallas, Fort Worth, Houston and San Antonio.
INVESTOR CONTACT
Heather Worley, 214.932.6646
[email protected]


OpenAI Hires OpenClaw Creator Peter Steinberger to Advance Next-Generation AI Agents
Anthropic’s Claude AI Reportedly Used in U.S. Operation to Capture Nicolas Maduro
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings
How Marco Pharma International Preserves German Homeopathic Traditions in America
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Disney Issues Cease-and-Desist to ByteDance Over Alleged AI Copyright Infringement
Warner Bros. Discovery Weighs Renewed Sale Talks With Paramount Skydance Amid Netflix Deal Review
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 



